• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重编程结核分枝杆菌 CRISPR 系统用于基因编辑和全基因组 RNA 干扰筛选。

Reprogramming Mycobacterium tuberculosis CRISPR System for Gene Editing and Genome-wide RNA Interference Screening.

机构信息

State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan 430070, China; College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China.

State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan 430070, China.

出版信息

Genomics Proteomics Bioinformatics. 2022 Dec;20(6):1180-1196. doi: 10.1016/j.gpb.2021.01.008. Epub 2021 Dec 16.

DOI:10.1016/j.gpb.2021.01.008
PMID:34923124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10225669/
Abstract

Mycobacterium tuberculosis is the causative agent of tuberculosis (TB), which is still the leading cause of mortality from a single infectious disease worldwide. The development of novel anti-TB drugs and vaccines is severely hampered by the complicated and time-consuming genetic manipulation techniques for M. tuberculosis. Here, we harnessed an endogenous type III-A CRISPR/Cas10 system of M. tuberculosis for efficient gene editing and RNA interference (RNAi). This simple and easy method only needs to transform a single mini-CRISPR array plasmid, thus avoiding the introduction of exogenous protein and minimizing proteotoxicity. We demonstrated that M. tuberculosis genes can be efficiently and specifically knocked in/out by this system as confirmed by DNA high-throughput sequencing. This system was further applied to single- and multiple-gene RNAi. Moreover, we successfully performed genome-wide RNAi screening to identify M. tuberculosis genes regulating in vitro and intracellular growth. This system can be extensively used for exploring the functional genomics of M. tuberculosis and facilitate the development of novel anti-TB drugs and vaccines.

摘要

结核分枝杆菌是结核病(TB)的病原体,它仍然是全球单一传染病导致死亡的主要原因。新型抗结核药物和疫苗的开发受到结核分枝杆菌复杂且耗时的遗传操作技术的严重阻碍。在这里,我们利用结核分枝杆菌内源性的 III-A 型 CRISPR/Cas10 系统进行高效的基因编辑和 RNA 干扰(RNAi)。这种简单的方法只需要转化单个 mini-CRISPR 阵列质粒,从而避免了外源蛋白的引入和最小化了蛋白毒性。我们证明了该系统可以有效地和特异性地敲入/敲除结核分枝杆菌基因,这一结果通过 DNA 高通量测序得到了证实。该系统进一步应用于单基因和多基因 RNAi。此外,我们成功地进行了全基因组 RNAi 筛选,以鉴定调控结核分枝杆菌体外和细胞内生长的基因。该系统可以广泛用于探索结核分枝杆菌的功能基因组学,并有助于开发新型抗结核药物和疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/de2b83f333d7/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/264aea68da94/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/86622c7a4d49/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/cdbe0e090c52/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/0aa37da89a3b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/49bfd776785c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/e67e36521ea3/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/de2b83f333d7/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/264aea68da94/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/86622c7a4d49/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/cdbe0e090c52/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/0aa37da89a3b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/49bfd776785c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/e67e36521ea3/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f9e/10225669/de2b83f333d7/gr7.jpg

相似文献

1
Reprogramming Mycobacterium tuberculosis CRISPR System for Gene Editing and Genome-wide RNA Interference Screening.重编程结核分枝杆菌 CRISPR 系统用于基因编辑和全基因组 RNA 干扰筛选。
Genomics Proteomics Bioinformatics. 2022 Dec;20(6):1180-1196. doi: 10.1016/j.gpb.2021.01.008. Epub 2021 Dec 16.
2
[Frontier of mycobacterium research--host vs. mycobacterium].[分枝杆菌研究前沿——宿主与分枝杆菌]
Kekkaku. 2005 Sep;80(9):613-29.
3
Mycobacterium tuberculosis type III-A CRISPR/Cas system crRNA and its maturation have atypical features.结核分枝杆菌 III-A 型 CRISPR/Cas 系统 crRNA 及其成熟具有非典型特征。
FASEB J. 2019 Jan;33(1):1496-1509. doi: 10.1096/fj.201800557RR. Epub 2018 Jul 6.
4
Characteristics of subtype III-A CRISPR-Cas system in Mycobacterium tuberculosis: An overview.结核分枝杆菌 III-A 型 CRISPR-Cas 系统的特征:概述。
Infect Genet Evol. 2023 Aug;112:105445. doi: 10.1016/j.meegid.2023.105445. Epub 2023 May 20.
5
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
6
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟,有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
7
[Recent progress in mycobacteriology].[分枝杆菌学的最新进展]
Kekkaku. 2007 Oct;82(10):783-99.
8
Strategies of genome editing in mycobacteria: Achievements and challenges.分枝杆菌基因组编辑策略:成就与挑战
Tuberculosis (Edinb). 2016 May;98:132-8. doi: 10.1016/j.tube.2016.03.005. Epub 2016 Mar 26.
9
Application of CRISPR-cas-based technology for the identification of tuberculosis, drug discovery and vaccine development.基于 CRISPR-cas 的技术在结核病鉴定、药物发现和疫苗开发中的应用。
Mol Biol Rep. 2024 Mar 29;51(1):466. doi: 10.1007/s11033-024-09424-6.
10
Application of combined CRISPR screening for genetic and chemical-genetic interaction profiling in .联合 CRISPR 筛选在 …… 中的遗传和化学生物遗传学相互作用分析中的应用。
Sci Adv. 2022 Nov 25;8(47):eadd5907. doi: 10.1126/sciadv.add5907. Epub 2022 Nov 23.

引用本文的文献

1
CRISPR-Cas in actinomycetes: still a lot to be discovered.放线菌中的CRISPR-Cas:仍有许多有待发现之处。
Microlife. 2025 Jun 12;6:uqaf010. doi: 10.1093/femsml/uqaf010. eCollection 2025.
2
Innovative Strategies for Combating Multidrug-Resistant Tuberculosis: Advances in Drug Delivery Systems and Treatment.对抗耐多药结核病的创新策略:药物递送系统与治疗的进展
Microorganisms. 2025 Mar 24;13(4):722. doi: 10.3390/microorganisms13040722.
3
Revolutionizing Tuberculosis Management With Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas Technology: A Comprehensive Literature Review.

本文引用的文献

1
The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types.基因组序列档案家族:走向爆炸式的数据增长和多样化的数据类型。
Genomics Proteomics Bioinformatics. 2021 Aug;19(4):578-583. doi: 10.1016/j.gpb.2021.08.001. Epub 2021 Aug 13.
2
Cyclic oligoadenylate signalling mediates Mycobacterium tuberculosis CRISPR defence.环状寡腺苷酸信号介导结核分枝杆菌 CRISPR 防御。
Nucleic Acids Res. 2019 Sep 26;47(17):9259-9270. doi: 10.1093/nar/gkz676.
3
Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis.
利用成簇规律间隔短回文重复序列(CRISPR)-Cas技术革新结核病管理:一项综合文献综述
Cureus. 2024 Oct 17;16(10):e71697. doi: 10.7759/cureus.71697. eCollection 2024 Oct.
4
High-efficiency genome editing of an extreme thermophile using endogenous type I and type III CRISPR-Cas systems.利用内源性I型和III型CRISPR-Cas系统对嗜热放线菌进行高效基因组编辑。
mLife. 2022 Dec 7;1(4):412-427. doi: 10.1002/mlf2.12045. eCollection 2022 Dec.
5
The Role of Rv1476 in Regulating Stress Response and Intracellular Survival of .Rv1476在调节应激反应及[具体细菌名称]细胞内存活中的作用 (注:原文中“of.”后缺少具体内容)
Curr Issues Mol Biol. 2024 Feb 16;46(2):1556-1566. doi: 10.3390/cimb46020100.
6
Epinephrine Stimulates Growth and Biofilm Formation.肾上腺素刺激生长和生物膜形成。
Int J Mol Sci. 2023 Dec 12;24(24):17370. doi: 10.3390/ijms242417370.
7
An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover.一种古菌病毒编码的抗 CRISPR 蛋白通过抑制 Cas RNP 复合物的周转来抑制 III-B 型免疫。
Nucleic Acids Res. 2023 Nov 27;51(21):11783-11796. doi: 10.1093/nar/gkad804.
8
Mycobacterial Genetic Technologies for Probing the Host-Pathogen Microenvironment.用于探测宿主-病原体微环境的分枝杆菌遗传技术。
Infect Immun. 2023 Jun 15;91(6):e0043022. doi: 10.1128/iai.00430-22. Epub 2023 May 30.
9
The future of CRISPR in Mycobacterium tuberculosis infection.CRISPR 在结核分枝杆菌感染中的未来。
J Biomed Sci. 2023 May 27;30(1):34. doi: 10.1186/s12929-023-00932-4.
10
CRISPR-Based Approaches for Gene Regulation in Non-Model Bacteria.基于CRISPR的非模式细菌基因调控方法。
Front Genome Ed. 2022 Jun 23;4:892304. doi: 10.3389/fgeed.2022.892304. eCollection 2022.
肠道菌群失调损害肺泡巨噬细胞对结核分枝杆菌的免疫。
Mucosal Immunol. 2019 May;12(3):772-783. doi: 10.1038/s41385-019-0147-3. Epub 2019 Feb 19.
4
Non-specific degradation of transcripts promotes plasmid clearance during type III-A CRISPR-Cas immunity.非特异性转录本降解促进 III-A 型 CRISPR-Cas 免疫期间质粒清除。
Nat Microbiol. 2019 Apr;4(4):656-662. doi: 10.1038/s41564-018-0353-x. Epub 2019 Jan 28.
5
ORBIT: a New Paradigm for Genetic Engineering of Mycobacterial Chromosomes.ORBIT:一种新型结核分枝杆菌染色体基因工程范式。
mBio. 2018 Dec 11;9(6):e01467-18. doi: 10.1128/mBio.01467-18.
6
Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference.CRISPR-Csm 复合物的结构研究揭示了共转录干扰的机制。
Cell. 2019 Jan 10;176(1-2):239-253.e16. doi: 10.1016/j.cell.2018.10.052. Epub 2018 Nov 29.
7
Genome-wide CRISPR-dCas9 screens in E. coli identify essential genes and phage host factors.全基因组 CRISPR-dCas9 筛选鉴定大肠杆菌必需基因和噬菌体宿主因子。
PLoS Genet. 2018 Nov 7;14(11):e1007749. doi: 10.1371/journal.pgen.1007749. eCollection 2018 Nov.
8
Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs.与肺结核相关的肠道微生物群及抗结核药物引起的微生态失调。
J Infect. 2019 Apr;78(4):317-322. doi: 10.1016/j.jinf.2018.08.006. Epub 2018 Aug 11.
9
A CRISPR-Cpf1-Assisted Non-Homologous End Joining Genome Editing System of Mycobacterium smegmatis.CRISPR-Cpf1 辅助的非同源末端连接基因组编辑系统在耻垢分枝杆菌中的应用。
Biotechnol J. 2018 Sep;13(9):e1700588. doi: 10.1002/biot.201700588. Epub 2018 Aug 6.
10
Mycobacterium tuberculosis type III-A CRISPR/Cas system crRNA and its maturation have atypical features.结核分枝杆菌 III-A 型 CRISPR/Cas 系统 crRNA 及其成熟具有非典型特征。
FASEB J. 2019 Jan;33(1):1496-1509. doi: 10.1096/fj.201800557RR. Epub 2018 Jul 6.